Anaphylactic reaction to the second dose of dacarbazine following initial exposure in patient with hodgkin lymphoma
- 11 August 2026
- journal article
- case report
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
Abstract
Introduction: Dacarbazine is generally well-tolerated, apart from its hematologic toxicities; however, rare and life-threatening anaphylactic reactions have been reported. We aimed to describe a rare case of anaphylactic reaction to dacarbazine following a previously tolerated first dose. Case Report: We report a case of a 69-year-old male patient with classical Hodgkin lymphoma, who was planned for nivolumab, doxorubicin, vinblastine, and dacarbazine (N + AVD) combination, day 1 and 15 every 28 days. The patient received day 1 of cycle#1, without any complications. On day 15, the patient developed a severe anaphylactic reaction 5 min after the start of dacarbazine infusion. The reaction was manifested by hypoxia, shivering, itching, and laryngeal edema. Management & Outcome: Patient required immediate interruption of dacarbazine infusion and received 10 mg of intravenous chlorphenamine and 200 mg of intravenous hydrocortisone initially with no improvement. Hypoxia and laryngeal edema improved following the administration of 0.3 mg intramuscular epinephrine. The patient was transferred to the intensive care unit for close monitoring due to increased risk of biphasic anaphylactic reaction, in which symptoms can recur after initial resolution. Oxygen saturation improved from 82% to 90–93%, and the patient remained hemodynamically stable without complications. Dacarbazine was discontinued. Patient continued nivolumab, doxorubicin, and vinblastine (N + AV) for five cycles, and achieved complete metabolic response. Discussion: This case highlights that anaphylactic reaction to dacarbazine may occur despite prior tolerance to the first dose. Physicians should suspect reaction during subsequent infusions of dacarbazine, even when initial cycle is tolerated.Keywords
This publication has 14 references indexed in Scilit:
- Mechanobiology of Type 1 hypersensitivity: Elucidating the impacts of mechanical forces in allergic reactionsMechanobiology in Medicine, 2024
- Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapiesBlood Cancer Journal, 2021
- Evidence update for the treatment of anaphylaxisResuscitation, 2021
- Mechanisms of human drug-induced anaphylaxisJournal of Allergy and Clinical Immunology, 2021
- Rapid desensitization to antineoplastic drugs in an outpatient immunoallergology clinicAnnals of Allergy, Asthma & Immunology, 2020
- Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factorsAnnals of Allergy, Asthma & Immunology, 2019
- Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysisThe Lancet Oncology, 2013
- Hypersensibilité à la dacarbazine chez les malades traités pour mélanome métastatiqueAnnales de Dermatologie et de Vénéréologie, 2006
- Biphasic anaphylactic reactionsAnnals of Allergy, Asthma & Immunology, 2005
- Clinical features and severity grading of anaphylaxisJournal of Allergy and Clinical Immunology, 2004